Efficacy and pharmacokinetics of a modified acid-labile docetaxel-PRINT® nanoparticle formulation against non-small-cell lung cancer brain metastases
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and pharmacokinetics of a modified acid-labile docetaxel-PRINT® nanoparticle formulation against non-small-cell lung cancer brain metastases
Authors
Keywords
-
Journal
Nanomedicine
Volume 11, Issue 15, Pages 1947-1955
Publisher
Future Medicine Ltd
Online
2016-07-26
DOI
10.2217/nnm-2016-0147
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Stimuli-responsive nanoparticles for targeting the tumor microenvironment
- (2015) Jinzhi Du et al. JOURNAL OF CONTROLLED RELEASE
- Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA-Mutated and BRCA-Wild-Type Triple-Negative Breast Cancer
- (2015) O. Karginova et al. MOLECULAR CANCER THERAPEUTICS
- Use of liposomal doxorubicin–cyclophosphamide combination in breast cancer patients with brain metastases: a monocentric retrospective study
- (2014) B. Linot et al. JOURNAL OF NEURO-ONCOLOGY
- Particle Replication in Nonwetting Templates Nanoparticles with Tumor Selective Alkyl Silyl Ether Docetaxel Prodrug Reduces Toxicity
- (2014) Kevin S. Chu et al. NANO LETTERS
- Current approaches to the treatment of metastatic brain tumours
- (2014) Taofeek K. Owonikoko et al. Nature Reviews Clinical Oncology
- pH-Sensitive nano-systems for drug delivery in cancer therapy
- (2013) Juan Liu et al. BIOTECHNOLOGY ADVANCES
- Selective Permeabilization of the Blood–Brain Barrier at Sites of Metastasis
- (2013) John J. Connell et al. JNCI-Journal of the National Cancer Institute
- Management of non-small-cell lung cancer: recent developments
- (2013) Martin Reck et al. LANCET
- Pharmacokinetics and Efficacy of PEGylated Liposomal Doxorubicin in an Intracranial Model of Breast Cancer
- (2013) Carey K. Anders et al. PLoS One
- Pharmacokinetics and Antitumor Efficacy of XMT-1001, a Novel, Polymeric Topoisomerase I Inhibitor, in Mice Bearing HT-29 Human Colon Carcinoma Xenografts
- (2012) M. D. Walsh et al. CLINICAL CANCER RESEARCH
- Incorporation and Controlled Release of Silyl Ether Prodrugs from PRINT Nanoparticles
- (2012) Matthew C. Parrott et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Plasma, tumor and tissue pharmacokinetics of Docetaxel delivered via nanoparticles of different sizes and shapes in mice bearing SKOV-3 human ovarian carcinoma xenograft
- (2012) Kevin S. Chu et al. Nanomedicine-Nanotechnology Biology and Medicine
- PRINT: A Novel Platform Toward Shape and Size Specific Nanoparticle Theranostics
- (2011) Jillian L. Perry et al. ACCOUNTS OF CHEMICAL RESEARCH
- Potent Engineered PLGA Nanoparticles by Virtue of Exceptionally High Chemotherapeutic Loadings
- (2011) Elizabeth M. Enlow et al. NANO LETTERS
- Heterogeneous Blood-Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer
- (2010) P. R. Lockman et al. CLINICAL CANCER RESEARCH
- Medical management of brain metastases from lung cancer (Review)
- (2009) Yamanaka ONCOLOGY REPORTS
- The effect of particle design on cellular internalization pathways
- (2008) S. E. A. Gratton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More